Back to all Programs

Register here

Related Materials

Past event

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

Viral Hepatitis and Liver Disease

How to End the Global HCV Epidemic - the role of injectables | David Thomas, MD, PhD

Viral Hepatitis and Liver Disease

Clinical Development of Long-Acting Broadly Neutralizing Monoclonal Antibodies: Lessons Learned Thus Far | Richard Koup, MD

Viral Hepatitis and Liver Disease

Viral Dynamics and the Search for an HIV Cure | Stephen Becker, MD

Viral Hepatitis and Liver Disease

The use of DAA’s in pregnancy in HCV infected mothers | David Burger, PharmD, PhD

Viral Hepatitis and Liver Disease

Application of Physiologically based pharmacokinetic (PBPK) Modelling to Drug Development Decisions | Joga Gobburu, PhD, MBA

Viral Hepatitis and Liver Disease

How/when will pharmacogenomics translate into improved clinical care? | David Haas, MD

Viral Hepatitis and Liver Disease

Last advances in HIV pharmacogenomics | Andrea Calcagno, MD, DTM&H

Viral Hepatitis and Liver Disease

Clinical Pharmacology of Integrase Inhibitors | Giovanni Di Perri, MD, PhD

Viral Hepatitis and Liver Disease

Update on DDI guidelines of the FDA - in vitro | Xinning Yang, PhD